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Abstract
The Covid-19 pandemic is currently ravaging the globe with enormous  
morbidity and mortality. This pandemic, caused by the SARS-CoV-2 started from 
China and has spread across the globe. Initial reports indicated that the SARS-
CoV-2 initially emerged among animals from where they transfer to humans. 
Different strategies deployed to curtail the pandemic have yielded little result. 
Therefore, the One-Health concept may compliment existing strategies. The One 
Health places emphasis on the between the animal-human-ecosystem interface and 
how this can be used to tackle public health problems, including the COVID-19 
pandemic. One Health Surveillance will involve tracking viral pathogens in animals 
to access risk of transfer to humans. It will also stimulate targeted approaches 
for prevention and treatment of viral zoonotic infections. There should be an 
integrated and interdisciplinary One-Health surveillance that should incorporate 
veterinary, medical or public health and environmental scientists to synergise 
surveillance effort to track emergence of infectious diseases in the future.
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1. Introduction
The One Health is an interdisciplinary concept that encompasses animal 
health, human health and the ecosystem with huge emphasis on how public health 
problems can be solved at the interface between these entities [1–3]. The interface 
between humans, animals and the ecosystem are intricately interconnected to the 
extent that whatever happens in any of these entities most likely affects others 
[4]. Therefore, the concept of One Health relies on the understanding that human 
health, animal health and the environment are intricately linked together and they 
can be affected simultaneously [5]. Historically, the nature of the intricate interac-
tions between animals, humans and the ecosystem have continued to shape human 
events and local or global public health [6].
There has been a historical consensus that some factors that affect human health 
can be traced to animal factors and origins [7]. Humans have coexisted with animals 
and this has formed the basis for studying the human-animal interface [8, 9]. For 
example, it has been confirmed that close to 70% of all infectious diseases have 
zoonotic origins [10–12]. It has also been implied in some scientific contexts that the 
control of aetiological agents in animals could prove effective in controlling such 
agents within the human population to improve public health [13, 14].
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Another imperative of the One Health is the growing interconnectedness 
between the ecosystems of humans, animals and the environment, which may 
include wildlife, urban areas and farming systems [15, 16]. The increasing anthro-
pological activities of humans have diminished the delineation between these 
ecosystems and have increased the frequency of contact between animals and 
humans [17]. Humans now stand at increased risk of having contact with animals 
that have been displaced from their original ecosystems. This has further increased 
the risks of emerging and re-emerging infectious diseases and their attendant 
burdens on humans and global economy ([18]. Some infectious diseases that were 
hitherto absent in human populations are now common due to the increased contact 
of humans with animals [19].
It has also been noted that some environmental factors affect the health of 
humans and animals [20]. The increasing anthropogenic activities have led to a 
distortion of the delicate natural environmental balance [21]. Intense industrial 
activities release greenhouse gases into the environment, leading to climate change 
and increased risk of respiratory problems among humans and animals. The 
activities of chemical and pharmaceutical industries have also been linked with the 
release of chemicals into the environment, particularly soil and water; and they can 
be absorbed by humans, animal and plants [22]. For instance, some studies have 
confirmed the residual amounts of antibiotics found in urine of animals are partly 
due to the release of pharmaceutical wastes into the environment [23]. Several 
pathogens, particularly viruses and bacteria, have been confirmed to be carried 
by environmental reservoirs and matrixes from where they can be transmitted to 
humans and animals to cause diseases [24]. One of the fallouts of globalization is the 
increased speed and frequency of travels by different channels of transportation, 
namely air, sea and land. This has facilitated the massive movement of humans and 
animals across transcontinental boundaries [25]. Unfortunately, humans that carry 
active infectious diseases serve as reservoir through which infectious pathogens can 
be transmitted or transferred across international boundaries [26, 27]. In addition, 
massive demand for protein and animal products increases the number of animals 
that are transported across international borders with increased risk of transfer of 
resident zoonotic flora and pathogens across international boundaries [28]. This 
factor has contributed to the increased interface between animals and humans.
It is within this context that different countries and international organizations, 
particularly the World Health Organization, (WHO), Organization for Animal 
Health (OIE) and Food and Agricultural Organization (FAO) agreed on a global 
consensus that some problems of global importance can be tackled through the 
One Health approach [29]. It places emphasis on multi-sectoral collaborations and 
frameworks to solve pertinent global health problems, both nationally and interna-
tionally. They also encourage different countries to come up with their One Health 
policies with a view to enhance the quality of their public health. Many countries 
across the globe have responded to this challenge and institutionalized One Health 
into their surveillance systems to improve public health. For instance, the African 
Center for Disease Control has incorporated the One Health framework into its 
activities with a view to tackle the periodic problem of emerging infectious diseases 
within the continent.
2. Brief review of zoonotic viruses and their epidemiology
Zoonotic infections are those infections that originate from animals and are 
transmitted through the agency of animals or insects to humans [30, 31]. It has 
since been on record that the vast majority of emerging infectious diseases have 
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zoonotic origins [32, 33]. It has also been established that many viruses have animals 
as their reservoirs and some even exist as part of the natural flora of the animals. 
Many animals that have served as proven reservoirs of viruses include bats, dogs, 
primates, and many other exotic species of animals [34]. It has been recognized 
that the knowledge of viruses and their natural hosts or ecosystems is important 
to effectively recognize measures to combat zoonotic infections, including those 
caused by viruses [35]. Such knowledge will enable scientists determine the pos-
sible viral flora of such animals, detect any seasonal changes in the carriage of such 
viruses that may negatively impact public health and allow medical practitioners, 
veterinary physicians and epidemiologists to predict possible emergence of viral 
infections, risks and threats to humans and public health [36–38].
A vast majority of infectious diseases that have significant toll on public 
health, in terms of mortality and morbidity, have zoonotic origins [39]. Similarly, 
viral zoonoses contribute a significant proportion of infectious diseases across 
the globe with significant economic burden running to billions of US dollars 
annually [37]. Furthermore, Africa and other developing countries appear to have 
the highest burden of viral zoonotic infections, with significant mortality and 
morbidity [40, 41]. The diminishing demarcation between the animal wildlife and 
human ecosystems increases the risk of contact and interaction between humans 
and animals with consequent increase in the surge of emerging and re-emerging 
infectious diseases in Africa and across the globe [42]. As stated above, Africa 
has its fair share of zoonotic viral diseases with well documented mortality and 
morbidity attributed to them. The following are examples of past or recent wave 
of zoonotic viral diseases in Africa.
i. Ebola virus disease: This is a usually fatal disease caused by the Ebola 
virus. It has been established that this disease is usually transmitted through 
contact of apparently healthy individuals with the body fluids of individuals 
infected with the virus [43, 44]. Earlier and recent reports suggest that the 
virus was originally found in primates and bats in wildlife from where they 
were transmitted to humans that came in contact with them [45, 46]. It can 
also be transmitted from wild animals such as fruit bats and porcupines 
[47]. The earliest reported case of the diseases was in 1976 in the Democratic 
republic of Congo [48]. The most pronounced outbreak of this disease was 
reported in 2014 in Liberia, Sierra Leone and Guinea with combined mor-
tality of approximately 11,000 deaths [49]. The fatal nature and the huge 
mortality reported in the recent outbreaks draws attention to the zoonotic 
origin of the disease and how it can be tackled through one health.
ii. Lassa fever: This disease is caused by the Lassa fever virus and is endemic 
mostly in Nigeria and other neighboring countries, including Cote d’Ivoire, 
Guinea, Central African Republic, Mali, Senegal and Congo [50]. The 
natural host of the virus is the rodent Mastomys natalensis, which is mostly 
found in tropical environments in West Africa [51]. This rodent is originally 
resident in the bushes and tropical rainforest but the increasing and massive 
urbanization in most parts of Nigeria and West Africa dislodge these rodents 
from their natural habitat, increasing the risk of transmission of this virus 
to humans [42]. Epidemiologically, the annual incidence of this disease in 
Africa is estimated at 200,000, with estimated mortality of 500 with 60 
million people at risk of contracting the disease [52, 53].
iii. Rabies: This disease is caused by the Rabies virus and it is found mostly 
in Africa and Asia [54]. It is a fatal disease with high mortality in endemic 
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regions where the disease is common. Relative to the high mortality associ-
ated with this disease, it is estimated that 99% of close to 59000 deaths 
caused by this disease are originated from dogs [55]. The virus also circulates 
in wildlife, especially wild bats and racoons where they can also be transmit-
ted to domestic animals that come in contact with them [55]. The strong 
knowledge of the transmission link of the virus between dogs and humans 
led the effective control of the disease through vaccination of dogs and this 
has proven effective till date ([56–58].
iv. Human Arbovirus infections: This represents the categories of infections 
that are caused by mosquitoes and ticks that feed on blood and transmit 
viruses to susceptible hosts during the process [59]. These Arboviruses still 
present a huge threat to public health especially in developing countries [60]. 
The morbidity and mortality associated with diseases caused by arbovi-
ruses is significant [61]. However, the increasing rate of urbanization and 
other related anthropogenic forces increase the chance of transmission of 
arboviruses to humans [62]. The most prominent arboviral infection among 
humans is the Dengue fever caused by the Dengue virus which accounts 
for more than 40.000 deaths per annum [63]. Around 2015, the Zika virus 
infection caused some morbidities and mortalities in Brazil and neighboring 
countries and still a threat till date [64].
It has been noted that the zoonotic origins, epidemiological burden and trans-
mission cycles of the viral infections emphasize the need for effective control of 
zoonotic viral infections through the One Health approach, especially in the para-
digm of other measures that have been adopted and have not effectively controlled 
the diseases.
3. Brief review of the COVID-19 pandemic
A new viral disease emerged in China and has since spread to different parts 
of the world with more than 145 million people infected and more than 3 million 
deaths. After extensive molecular studies, the etiology of the virus was identified 
as SARS-COV-2 with innate ability to spread rapidly among humans [65–68]. 
Furthermore, new variants of the virus were later identified in different countries 
with enhanced abilities to spread faster than the previous wild types discovered. 
This implies that more people will be infected and more may likely die of this 
disease. These new variants therefore appear to have altered the epidemiology of 
the disease in some parts of the world [69–72].
Different countries, international and scientific organizations responded 
swiftly to the spread of the pandemic with an array of measures to limit the spread 
of the disease across national and international boundaries [73, 74]. Such measures 
included isolation and quarantine, restriction of international flights, social dis-
tancing and personal hygiene, which include hand washing and use of nose masks 
[74–78]. Following global agreement that vaccines may likely end the pandemic, 
different companies and research organisations have developed vaccines and the 
largest and unprecedented vaccination drive have since commenced in different 
countries and millions more people have been projected to be vaccinated over time 
[79, 80].
However, the different initiatives intended to control the spread of the disease 
shortly before the vaccines were discovered appeared to have limited effects in 
controlling the spread of the disease. For instance, strict hand washing remains 
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a challenge in many poor and developing countries due to lack of adequate water 
supply [78]. Furthermore, the screening measures at international airports only 
captures symptomatic carriers while asymptomatic carriers can escape the screen-
ing routines [77]. Also, most of these measures appear short term and may not be 
sustained on these long run [81]. Inadequate logistics for distribution of masks 
and other sanitary materials limit access by people in remote areas. The limited 
success achieved in limiting the spread of the disease calls for more deliberate and 
innovative approaches towards controlling the spread and even eliminating the 
disease.
4. Zoonotic origin of COVID-19
The preliminary investigations in China that followed the onset of the pandemic 
revealed that bats and exotic animals at a popular market are the initial sources of 
the organisms [82, 83]. It was also hypothesized that the humans that initially came 
into contact with the animals may have triggered the pandemic [84]. The coronavi-
ruses are a large family of viruses that has been found to be common among animals 
and wildlife, including bats [82]. The initial strains of the virus were genomically 
correlated with that of bats. This implies that the virus may have originated from 
bats, although the exact transmission to animals remains relatively unknown [84]. 
The extensive zoonotic origin of these types of viruses heightens the risk of their 
transfer from the wildlife to the human population [85]. The growing urbaniza-
tion, anthropogenic pressure and climate change encroaches the original wildlife, 
resulting in the spillover of the viruses as the animals migrate to areas inhabited by 
humans [86].
5. The imperative of one health surveillance
The initial transfer pattern of the virus from animals and wild life to the envi-
ronment and humans confirms that the One Health approach can be applied to 
tackle the spread of the diseases, in view of the outright failure or limited success 
achieved with other preliminary methods deployed to control the transmission of 
the disease [81, 87]. Animals serve as the reservoir of the virus from where they can 
be shed into the environment. Such animals, usually in wildlife, frequently come 
into contact with humans and they transmit the virus in the process. Furthermore, 
humans can serve as conduit to transfer to other humans and this scenario is 
particularly problematic in the case of the SARS-CoV-2 [88]. In addition, humans 
can also transmit the virus asymptomatically to other humans and the environment 
[89]. The virus has been found on surfaces, foods and sewages [90].
There is a strong consensus in the global scientific arena that the One Health 
concept provides a stronger approach to tackle the spread of infectious diseases 
including those caused by zoonotic viruses. In response, different international 
organizations have put up strong statements in support of the One Health 
approach to tackle the current surge of infectious diseases. They further encourage 
different countries to prioritize this concept and come up with policies to tackle 
the spread of infectious diseases, which can be extended to the current COVID-19 
pandemic.
In major effort to solidify the One Health footprint on global public health, three 
major international organizations, namely the World Health Organization (WHO), 
Food and Agricultural Organization (FAO) and the Organization for Animal Health 
(OIE) produced a joint and strategic framework aimed at reducing infectious 
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diseases at the animal-humans-ecosystem interface. With strong link of the coro-
navirus with wild life and the environment, viral diseases of zoonotic origins also 
fall with the scope of infectious diseases that can be tackled through the One-Health 
policy [91].
Several countries have since keyed into the strategic initiatives and have rec-
ognized it as an important approach to tackle the surge of emerging infectious 
diseases, including the current COVID-19 pandemic. For instance, the African 
Center for Disease Control has incorporated it into its public health programmes 
in the continent [29]. The European Union (EU) have since produced its own 
One Health action plan to tackle different public health problems most especially 
antibiotic resistance and zoonoses [92]. Similarly, the Asia continent has the One 
Health Tripartite frame work the comprises of the Asia region of the WHO, FAO 
and OIE to give full attention to One Heal issues with a view to tackle public health 
challenges that most especially antibiotic resistance and zoonoses [93].
However, it appears there is no standard approach for tackling COVID-19 as a 
means to prevent further spread of the pandemic. This can be viewed from the fact 
that the pandemic is relatively new and it may take some time to design One health 
policies that will specifically suit the pandemic. One of the key peculiarities of the 
current pandemic is the easy spread of the COVID-19, compared with the other pub-
lic health threats that are currently being addressed by One Health. Also, the massive 
mortality and morbidity of the current pandemic is another peculiarity for which 
custom made One Health policies should be designed to tackle the current pandemic. 
Generally, the One Health approach recognizes that scientific expertise should be 
drawn from disciplines, most especially, medicine, veterinary science and environ-
mental science in order to public health threats including the current COVID-19.
6. Surveillance for infectious diseases
The surveillance for infectious diseases is a very crucial epidemiological tool 
that serves different purposes in public health. More specifically, infectious dis-
eases surveillance can be used to determine the current prevalence of infectious 
diseases at a given time. It also assists in the monitoring of changes in infectious 
diseases trend over time. It helps to determine or reveal risks of emergence of 
infectious diseases and how such risks can be mitigated. More importantly, infec-
tious diseases surveillance allows targeted policies for prevention and control of 
infectious diseases within particular groups within a population [94].
Within the COVID-19 pandemic, the extensive surveillance capacities and pro-
tocols developed over the years have assisted in tracking the spread of the pandemic 
and helped to determine the massive threat it has posed in terms of morbidity and 
mortality [95, 96]. The massive surveillance efforts put forward, most especially by 
developed countries and China has enhanced targeted policies to tackle the spread 
of the disease and treatment. For instance, the United Kingdom recently announced 
massive vaccinations for the entire country. China was able to track sporadic 
emergence of the diseases and targeted quarantine followed such efforts. In con-
trast, African countries seem to have limited capacities for surveillance of infectious 
diseases and this may partly explain the low prevalence of the diseases in Africa.
7. One health surveillance
The paradigm of surveillance for the COVID-19 pandemic within the one health 
concept is somewhat different. Due to the interdisciplinary nature of one health, 
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surveillance efforts and policies should be designed to encompass human health or 
population, animal health and the ecosystem. In fact, this surveillance approach has 
been recognized as a crucial component of One Health and this integrated approach 
can be used to track emerging and re-emerging diseases. Surveillance efforts 
targeted at animals and wild life has revealed that coronaviruses, including the 
SARS-CoV-2 constitute part of the flora of such animals. Although the immediate 
animal to human transmission of the SARS-CoV-2 could not be established, direct 
human to human transmission has been established and this has been attributed 
to the vast majority of the transmission of the virus. The virus has also been found 
in solid household waste, sewage and hospital droplets and these carry the risk of 
transmitting the virus to susceptible individuals [97].
8. Conclusion
The One Health concept is a relatively new approach being promoted as a 
 strategy to tackle some public health problems at the human-animal-ecosystem 
interface. Consequently, its application is gradually gaining traction and some 
time is needed to really access its benefits. Currently, there are few evidence of the 
potential and practical benefits of this approach to tackle public health challenges on 
the scale of those posed by the COVID-19 pandemic.
That notwithstanding, few instances of the immediate, potential and practical 
benefit of using the One Health approach have emerged. The United States Agency 
for International development recently developed a PREDICT One Health surveil-
lance system to track potential emergence of pathogenic viruses and their possible 
spill-over to the human population. The successful application of this project has 
led to the improvement of our understanding of evolution of viruses on a global 
scale [98]. Furthermore, another coordinated One Health simulation study using 
the Rift Valley virus was used to demonstrate the potential applicability and success 
of this approach. The study concluded that a multidisciplinary investigation using 
this approach can yield a higher statistical power and reveal complex relationships 
between regarding the epidemiology of the virus in animal and environmental 
settings [99].
It is evident from the foregoing that the One Health surveillance initiative can be 
applied at the human-animal-ecosystem interface to track any emerging infectious 
diseases. The incorporation of molecular techniques can be used to establish the 
clonality between the viral strains among animals, humans and the ecosystem. Due 
to the massive and devastating nature of the COVID-19 pandemic, the One Health 
surveillance must be globally envisioned in order to effectively track and control the 
spread of the disease [100].
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